Günther P Amminger

10PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersCounselling psychologyLegal institutions (incl. courts and justice systems)Biologically active moleculesPsycholinguistics (incl. speech production and comprehension)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 07, 2026
Feasibility of a Stepped-Care Intervention for Those at Clinical High Risk for Psychosis in the United States.

Daniel I Shapiro, Rebecca E Grattan, Jill R Laquidara

|Apr 10, 2024
An open label pilot trial of low-dose lithium for young people at ultra-high risk for psychosis.

Simon M Rice, Barnaby Nelson, G Paul Amminger

|May 11, 2023
The promise of the therapeutic use of cannabidiol for psychiatric disorders.

G Paul Amminger, Rebekah Street, Christopher G Davey

|Apr 18, 2023
Influence of cannabis use on incidence of psychosis in people at clinical high risk.

Lucy A Chester, Lucia R Valmaggia, Matthew J Kempton

|Jul 17, 2021
Letter to the Editor: Cannabidiol Treatment-Is There an Effect on Cognitive Functioning, Quality of Life, and Behavior? A Case Report.

Claudia M Klier, Günther P Amminger, Oswald D Kothgassner

Pageof 2